Paediatric drug optimization for COVID-19: meeting report, 6 September 2022

Towards investigation, development and introduction of cefiderocol in children: product brief

Report of a WHO expert consultation on dosing to enable implementation of treatment recommendations in the WHO consolidated guidelines on the management of TB in children and adolescents

Use of bedaquiline in children and adolescents with multidrug- and rifampicin-resistant tuberculosis – Information note

WHO Pharmaceuticals Newsletter: No.1, 2024

A case study on the ecosystem for local production of pharmaceuticals, vaccines, and biologicals: the Nigeria context

Paediatric drug optimization for tuberculosis: meeting report, October 2023

Guidance on implementation of a quality system in blood establishments

Implementation of the Global strategy and plan of action on public health innovation and intellectual property: report on the Member States consultation 2023-2024

Policies to protect children from the harmful impact of food marketing: WHO guideline

Digital adaptation kit for child health (0-59 months) in humanitarian emergencies: operational requirements for implementing WHO recommendations in digital systems

Considerations for introducing new antiretroviral drug formulations for children: policy brief

WHO recommendations for care of the preterm or low birth weight infant

Hidden depths: the global investment case for drowning prevention

How the marketing of formula milk influences our decisions on infant feeding: report – Mexico

Clarification on sponsorship of health professional and scientific meetings by companies that market foods for infants and young children: information note

How the marketing of formula milk influences our decisions on infant feeding: report - South Africa

Research and development landscape for childhood cancer: a 2023 perspective

Accelerating anaemia reduction: a comprehensive framework for action

WHO acceleration plan to stop obesity